BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter regarding Regranex® Gel (becaplermin): Discontinuation of distribution in Europe

Active substance: becaplermin

According to information from the pharmaceutical manufacturer, the distribution of Regranex® Gel (becaplermin 0.01%) in Europe will be discontinued as of 30 June.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 336KB, File is accessible